Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary Successful strategies for treating type 1 diabetes need to restore the function of pancreatic beta cells that are destroyed by the immune system and overcome further destruction of insulin-producing cells. Here, we infused adeno-associated virus carrying Pdx1 and MafA expression cassettes through the pancreatic duct to reprogram alpha-cells into functional beta-cells, and normalized blood glucose in both beta-cell-toxin-induced diabetic mice and in autoimmune non-obese diabetic (NOD) mice. The euglycemia in toxin-induced diabetic mice and new insulin+ cells persisted in the autoimmune NOD mice for 4 months prior to reestablishment of autoimmune diabetes. This gene therapy strategy also induced alpha to beta cell conversion in toxin-treated human islets, which restored blood glucose levels in NOD/SCID mice upon transplantation. Hence, this strategy could represent a new therapeutic approach, perhaps complemented by immunosuppression, to bolster endogenous insulin production. Our study thus provides a potential basis for further investigation in human type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss
Thorel, F., Népote, V., Avril, I., Kohno, K., Desgraz, R., Chera, S., & Herrera, P. L. (2010) · Nature · doi:10.1038/nature08894 · Cited by 1,136 · cited 3×
“…2004; Kopinke et al., 2011; Kopp et al., 2011b; Meier et al., 2008; Pan et al., 2013; Rankin et al., 2013; Solar et al., 2009; Teta et al., 2007; Tonne et al., 2014; Xiao et al., 2013a, 2013c, 2013d), except for a few rare situations (Baeyens et al., 2014; Chera et al., 2014; Thorel et al., 2010).”
BackgroundMeier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683 · cited 2×
“, 2010), accumulating evidence does not support a substantial contribution of beta cell neogenesis to a functional beta cell mass in the adult pancreas (Cavelti-Weder et al., 2013; Chintinne et al., 2012; Desai et al., 2007; Dor et al., 2004; Georgia and Bhushan, 2004; Kopinke et al., 2011; Kopp et al., 2011b; Meier e…”
BackgroundThe NOD mouse model of type 1 diabetes: As good as it gets?
Atkinson, M. A., & Leiter, E. H. (1999) · Nature Medicine · doi:10.1038/9442 · Cited by 588 · cited 5×
“These latter data further support that the autoimmunity of the NODmice is intact and is behaving as if it were not actively being exposed to beta cell antigens at the time of transplant and thus showed a slightly delayed response to the transplanted islets.”
InfluentialDiabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers
Chera, S., Baronnier, D., Ghila, L., Cigliola, V., Jensen, J. N., Gu, G., Furuyama, K., Thorel, F., Gribble, F. M., Reimann, F., et al. (2014) · Nature · doi:10.1038/nature13633 · Cited by 410
Preexisting pancreatic acinar cells contribute to acinar cell, but not islet β cell, regeneration
Desai, B. M., Oliver-Krasinski, J., De Leon, D. D., Farzad, C., Hong, N., Leach, S. D., & Stoffers, D. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29988 · Cited by 303 · cited 2×
“, 2010), accumulating evidence does not support a substantial contribution of beta cell neogenesis to a functional beta cell mass in the adult pancreas (Cavelti-Weder et al., 2013; Chintinne et al., 2012; Desai et al., 2007; Dor et al., 2004; Georgia and Bhushan, 2004; Kopinke et al., 2011; Kopp et al., 2011b; Meier e…”
BackgroundVendrame, F., Pileggi, A., Laughlin, E., Allende, G., Martin-Pagola, A., Molano, R. D., Diamantopoulos, S., Standifer, N., Geubtner, K., Falk, B. A., et al. (2010) · Diabetes · doi:10.2337/db09-0498 · Cited by 215
Xiao, X., Wiersch, J., El-Gohary, Y., Guo, P., Prasadan, K., Paredes, J., Welsh, C., Shiota, C., & Gittes, G. K. (2013) · Diabetes · doi:10.2337/db12-1428 · Cited by 102 · cited 16×
“Here, we used a transgenic mouse model that allows lineage tracing of alpha cells, and we delivered Pdx1 and MafA expression vector virus to the mouse pancreas through a recently developed pancreatic intraductal infusion system (Xiao et al., 2014a, 2014b, 2013c, 2014c).”
MethodResultSelf-citation
Cited by
Direct cell reprogramming: approaches, mechanisms and progress
Wang, H., Yang, Y., Liu, J., & Qian, L. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00335-z · Cited by 444
Zhou, Q., & Melton, D. A. (2018) · Nature · doi:10.1038/s41586-018-0088-0 · Cited by 385
The α-cell in diabetes mellitus
Gromada, J., Chabosseau, P., & Rutter, G. A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0097-y · Cited by 143
Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy
Nair, G. G., Tzanakakis, E. S., & Hebrok, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0375-3 · Cited by 134
Gene therapy - can it cure type 1 diabetes
Srinivasan, M., Thangaraj, S. R., & Arzoun, H. (2021) · Cureus · doi:10.7759/cureus.20516 · Cited by 11
Metadata
- Authors
- Xiao, X., Guo, P., Shiota, C., Zhang, T., Coudriet, G. M., Fischbach, S., Prasadan, K., Fusco, J., Ramachandran, S., Witkowski, P., Piganelli, J. D., & Gittes, G. K.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 22
- Issue
- 1
- Pages
- 78-90.e4
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W2781653608
- Cited by
- 194
- References
- 9
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.